<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">EUROPEAN SYNCHROTRON RADIATION FACILITY</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<title level="a" type="main">EUROPEAN SYNCHROTRON RADIATION FACILITY</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">2C27E04F6E8143D559ACE40440F139AF</idno>
					<note type="submission">Once completed, the report should be submitted electronically to the User Office via the User</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-23T13:59+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><ref type="url" target="https://wwws.esrf.fr/misapps/SMISWebClient/protected/welcome.do">https://wwws.esrf.fr/misapps/SMISWebClient/protected/welcome.do</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Reports supporting requests for additional beam time</head><p>Reports can be submitted independently of new proposalsit is necessary simply to indicate the number of the report(s) supporting a new proposal on the proposal form.</p><p>The Review Committees reserve the right to reject new proposals from groups who have not reported on the use of beam time allocated previously.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Reports on experiments relating to long term projects</head><p>Proposers awarded beam time for a long term project are required to submit an interim report at the end of each year, irrespective of the number of shifts of beam time they have used.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Report:</head><p>The general purpose of this experiment was to investigate the interaction of the classical malaria drug</p><p>Chloroquine with an infected red blood cell in vivo. As in previous experiments a snapshot of the in-vivo condition was reached by high pressure cryo-freezing of the hydrated infected red blood cell. We have shown in the past 1 that the combination of soft X-ray tomography and fluorescence imaging of the same red blood cell can enable a biochemistry analysis of the concentration of hemoglobin, potassium, and hemozoin crystals as well as the drug in different organelles of the cell such as the parasite digestive vacuole or its cytosol, and the cytosol of the red blood cell outside the parasite. The analysis requires scrutinizing care, and within the short period (less than two weeks) between the experiment and the deadline for submission of this report this has not been possible to accomplish. Nevertheless, we are convinced that the quality of the data obtained will enable us to do so in the near future.</p><p>There is however one important aspect of the experiment that we are able to report on, and that is the interaction between the drug and hemozoin (Hz) crystals. Detailed calculations <ref type="bibr" target="#b1">2,</ref><ref type="bibr" target="#b2">3</ref>  We have therefore proposed a continuation of our experiment to be carried out with the 33.6 keV optics which will furthermore enable us to also investigate another promising drug of the quinoline family, namely RuQ. </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><figDesc>Mechanisms of quinoline-family drug action and drug resistance in the malaria parasite Plasmodium falciparum Names and affiliations of applicants (* indicates experimentalists): Sergey Kapishnikov, University of Copenhagen, Denmark Jens Als-Nielsen, University of Copenhagen, Denmark Leslie Leiserowitz, Weizmann Institute of Science, Israel</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><figDesc>figure below. The two panels show the fluorescence images of Fe atoms, bound to heme comprising Hz crystals, and Br atoms bound in the drug molecule BrQ. The figure shows unambiguously that the drug molecules have a pronounced affinity to bind to the crystal faces, and a scrutinizing analysis will reveal whether it corresponds to a sub-monolayer, a mono-layer (or more) of drug molecules on the surface of the Hz crystal. The image would be even more informative with the beam focus closer to its theoretical value of 12 nm 4 rather than the 30-50 nm achieved at 17.1 keV because with a 12 nm resolution one could have identified the (h,k,l)-Miller indices of the faces of the Hz crystal by its morphology and observed whether the BrQ binding depends on the face Miller indices as expected by the theoretical calculation alluded to above. This is important in a wider perspective, because if confirmed the reliability of the theoretical model would be enhanced considerably and would stimulate computation of modified drug molecules eventually leading to a better drug.The discrepancy between the observed and the theoretical focal spot size is due to a manufacture imperfection in the KB optics available at 17.05 keV. It was recently shown by the beamline staff 4 that the KB optics available for 33.6 keV was indeed very close to being perfect with a resulting focal spot size of only 13 nm.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 1 X</head><label>1</label><figDesc>Figure 1 X-ray fluorescence maps from a bromoquine-affected hemozoin crystal.</figDesc><graphic coords="3,107.80,483.35,235.90,170.40" type="bitmap" /></figure>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Biochemistry of malaria parasite infected red blood cells by X-ray microscopy</title>
		<author>
			<persName><forename type="first">S</forename><surname>Kapishnikov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Leiserowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Cloetens</surname></persName>
			<idno type="ORCID">0000-0002-4129-9091</idno>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Pereiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Awamu Ndonglack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Matuschewski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Als-Nielsen</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41598-017-00921-2</idno>
	</analytic>
	<monogr>
		<title level="j">Scientific Reports</title>
		<title level="j" type="abbrev">Sci Rep</title>
		<idno type="ISSNe">2045-2322</idno>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">802</biblScope>
			<date type="published" when="2017-04-11">2017</date>
			<publisher>Springer Science and Business Media LLC</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Kapishnikov, S., Leiserowitz, L., Yang, Y., Cloetens, P., Pereiro, E., Awamu Ndonglack, F., Matuschewski, K. &amp; Als-Nielsen, J. Scientific Reports 7, 802 (2017).</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Quinoline Binding Site on Malaria Pigment Crystal: A Rational Pathway for Antimalaria Drug Design</title>
		<author>
			<persName><forename type="first">Ronit</forename><surname>Buller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Matthew</forename><forename type="middle">L</forename><surname>Peterson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Örn</forename><surname>Almarsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Leslie</forename><surname>Leiserowitz</surname></persName>
		</author>
		<idno type="DOI">10.1021/cg025550i</idno>
	</analytic>
	<monogr>
		<title level="j">Crystal Growth &amp; Design</title>
		<title level="j" type="abbrev">Crystal Growth &amp; Design</title>
		<idno type="ISSN">1528-7483</idno>
		<idno type="ISSNe">1528-7505</idno>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="553" to="562" />
			<date type="published" when="2002-08-27">2002</date>
			<publisher>American Chemical Society (ACS)</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Buller, R., Peterson, M. L., Almarsson, O. &amp; Leiserowitz, L. Cryst Growth Des 2, 553-562 (2002).</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">The Antimalarial Ferroquine: Role of the Metal and Intramolecular Hydrogen Bond in Activity and Resistance</title>
		<author>
			<persName><forename type="first">Faustine</forename><surname>Dubar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Timothy</forename><forename type="middle">J</forename><surname>Egan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Bruno</forename><surname>Pradines</surname></persName>
		</author>
		<author>
			<persName><forename type="first">David</forename><surname>Kuter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Kanyile</forename><forename type="middle">K</forename><surname>Ncokazi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Delphine</forename><surname>Forge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jean-François</forename><surname>Paul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Christine</forename><surname>Pierrot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Hadidjatou</forename><surname>Kalamou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jamal</forename><surname>Khalife</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Eric</forename><surname>Buisine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Christophe</forename><surname>Rogier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Hervé</forename><surname>Vezin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Isabelle</forename><surname>Forfar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Christian</forename><surname>Slomianny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Xavier</forename><surname>Trivelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Sergey</forename><surname>Kapishnikov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Leslie</forename><surname>Leiserowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Daniel</forename><surname>Dive</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Christophe</forename><surname>Biot</surname></persName>
		</author>
		<idno type="DOI">10.1021/cb100322v</idno>
	</analytic>
	<monogr>
		<title level="j">ACS Chemical Biology</title>
		<title level="j" type="abbrev">ACS Chem. Biol.</title>
		<idno type="ISSN">1554-8929</idno>
		<idno type="ISSNe">1554-8937</idno>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="275" to="287" />
			<date type="published" when="2011-01-07">2011</date>
			<publisher>American Chemical Society (ACS)</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Dubar, F., J.Egan, T., Pradines, B., Kuter, D., Ncokazi, K. K., Forge, D., Paul, J.-F., Pierrot, C., Kalamou, H., Khalife, J., Buisine, E., Rogier, C., Vezin, H., Forfar, I., Slomianny, C., Trivelli, X., Kapishnikov, S., Leiserowitz, L., Dive, D. &amp; Biot, C. ACS Chemical Biology 6, 275-287 (2011).</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">Cesar</forename><surname>Da Silva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Pacureanu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Bohic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Morawe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Barrett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Cloetens</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">P. Optica</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cesar da Silva, J., Pacureanu, A., Yang, Y., Bohic, S., Morawe, C., Barrett, R. &amp; Cloetens, P. Optica 4 (2017).</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
